Literature DB >> 23685878

Characterisation of in vivo release of gentamicin from polymethyl methacrylate cement using a novel method.

Jason Crispin Webb1, Herbert Gbejuade, Andrew Lovering, Robert Spencer.   

Abstract

PURPOSE: The purpose of this study was to investigate the in vivo elution kinetics of gentamicin from bone cement by assessing antibiotic levels in the urine.
METHODS: Urinary samples of 35 patients who had undergone primary total hip arthroplasty were collected post-operatively. Gentamicin concentrations were analysed using the fluorescence polarisation immunoassay technique.
RESULTS: The mean duration of urinary gentamicin release in all cases was 43 days (range 13-95). There was still detectable gentamicin at the final collection in 20% (7/35) of cases, and in these cases, the mean gentamicin release was 71 days.
CONCLUSIONS: From the assessment of urinary gentamicin, we were able to demonstrate the biphasic gentamicin elution from bone cement. In addition, there were detectable concentrations of the antibiotic from the urinary samples for prolonged periods of up to two to six months. Our study indicates that the assessment of urinary antibiotics can offer a non-invasive method of monitoring the in vivo release kinetics of antibiotics from bone cement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685878      PMCID: PMC3779555          DOI: 10.1007/s00264-013-1914-5

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  24 in total

Review 1.  Antibiotic resistance of bacteria in biofilms.

Authors:  P S Stewart; J W Costerton
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

2.  Bacterial survival in the interfacial gap in gentamicin-loaded acrylic bone cements.

Authors:  J G E Hendriks; D Neut; J R van Horn; H C van der Mei; H J Busscher
Journal:  J Bone Joint Surg Br       Date:  2005-02

Review 3.  Biofilm theory can guide the treatment of device-related orthopaedic infections.

Authors:  J William Costerton
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

4.  Retention treatment after periprosthetic total hip arthroplasty infection.

Authors:  Ho-Rim Choi; Fabian von Knoch; Abdurrahman O Kandil; David Zurakowski; Slade Moore; Henrik Malchau
Journal:  Int Orthop       Date:  2011-07-27       Impact factor: 3.075

5.  Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses.

Authors:  Bernd Fink; Sebastian Vogt; Martin Reinsch; Hubert Büchner
Journal:  Clin Orthop Relat Res       Date:  2011-06-16       Impact factor: 4.176

Review 6.  Scenery of Staphylococcus implant infections in orthopedics.

Authors:  Lucio Montanaro; Pietro Speziale; Davide Campoccia; Stefano Ravaioli; Ilaria Cangini; Giampiero Pietrocola; Sandro Giannini; Carla Renata Arciola
Journal:  Future Microbiol       Date:  2011-11       Impact factor: 3.165

7.  Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement.

Authors:  D K Kuechle; G C Landon; D M Musher; P C Noble
Journal:  Clin Orthop Relat Res       Date:  1991-03       Impact factor: 4.176

8.  Increasing risk of revision due to deep infection after hip arthroplasty.

Authors:  Håvard Dale; Geir Hallan; Geir Hallan; Birgitte Espehaug; Leif I Havelin; Lars B Engesaeter
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

9.  The pharmacokinetics of Simplex-tobramycin bone cement.

Authors:  G J Sterling; S Crawford; J H Potter; G Koerbin; R Crawford
Journal:  J Bone Joint Surg Br       Date:  2003-07

10.  Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo.

Authors:  Konstantinos Anagnostakos; Philippe Wilmes; Eduard Schmitt; Jens Kelm
Journal:  Acta Orthop       Date:  2009-04       Impact factor: 3.717

View more
  1 in total

1.  Elution of antibiotics from poly(methyl methacrylate) bone cement after extended implantation does not necessarily clear the infection despite susceptibility of the clinical isolates.

Authors:  Matthew C Swearingen; Jeffrey F Granger; Anne Sullivan; Paul Stoodley
Journal:  Pathog Dis       Date:  2015-11-01       Impact factor: 3.166

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.